James W. Lee, MD

Hematology Oncology Associates, PCAlbuquerque, New Mexico - 87106 (505-272-4551) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS3
- SINCE2010

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer
April 2010 - August 2012
Colorectal Neoplasms
Foliri
Foliri Plus E7820
Folfiri Plus Bevacizumab



